Soluble recombinant botulinum toxin proteins
AssigneeAllergan, Inc., Allergan Botox Limited
InventorJames Williams
Life of this patent
Estimating the term…
Abstract
The present invention includes recombinant proteins derived from Clostridium botulinum toxins. In particular, soluble recombinant Clostridium botulinum type A, type B and type E toxin proteins are provided. Methods which allow for the isolation of recombinant proteins free of significant endotoxin contamination are provided. The soluble, endotoxin-free recombinant proteins are used as immunogens for the production of vaccines and antitoxins. These vaccines and antitoxins are useful in the treatment of humans and other animals at risk of intoxication with clostridial toxin.
Claims9
1-24. (canceled)
A soluble recombinant botulinum toxin, comprising the Clostridium botulinum a toxin amino acid sequence of SEQ ID NO:23, the toxin being obtained from an aerobic host cell by a process of recombinantly expressing the toxin using the aerobic host cell, the toxin being soluble.
Dependencies are inferred from the claim text.